Offering a combination of simplified and personalized scanning for patients at significantly lower lifecycle costs than other dual-source CT systems, the Somatom Pro.Pulse may be a viable option for smaller rural facilities and outpatient imaging centers.
Emphasizing significantly less power consumption than other dual-source computed tomography (CT) devices, the newly launched Somatom Pro.Pulse system may facilitate increased access to this technology at smaller facilities.
Siemens Heathineers, the manufacturer of Somatom Pro.Pulse, said the system can be utilized at up to 20 percent less power consumption than previous iterations of dual-source CT. This increased energy efficiency and an improved cooling system have contributed to significantly reduced lifecycle costs for the Somatom Pro.Pulse, according to the company.
Other advantages with the system include myExam Companion, which facilitates optimal CT scan parameters based on patient data and other considerations, such as breath-hold capabilities and heart rate. Siemens Healthineers said the Somatom Pro.Pulse also features a FAST (fully assisting scanner technologies) 3D camera that allows automated patient positioning. The company added that the system’s use of tin filters preserves low radiation dosing while ensuring optimal image quality.
“With our new advanced dual source CT scanner, we aim to make this high-class technology available to more patients,” noted Philipp Fischer, the head of computed tomography at Siemens Healthineers. “CT exams performed on this system follow an intelligent and intuitive workflow appealing to various levels of experience. This enables standardization and reproducibility for clinicians and thus saves personnel capacities.”
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Twenty Years of CT Colonography for Colorectal Cancer Screening: What the Research Reveals
August 2nd 2025Computed tomography colonography (CTC) demonstrated a 91.6 percent positive predictive value (PPV) for polyps > 6 mm, according to new research involving over 9,000 patients who underwent CTC for primary asymptomatic colorectal cancer screening.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 2nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.